Progressive Multifocal Leukoencephalopathy
What's New
Last Posted: Oct 04, 2023
- No association between HLA -B*57:01 and prevalence and/or outcome of progressive multifocal leukoencephalopathy in a French Nationwide HIV cohort.
Solen Secher, et al. AIDS research and human retroviruses 2023 0 - Molecular epidemiology of JC polyomavirus in HIV-infected patients and healthy individuals from Iran.
Makvandi Manoochehr, et al. Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] 2019 0 (1) 37-43 - Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses.
Serra López-Matencio Jose M, et al. Frontiers in neurology 2021 0 716548 - Database and Statistical Analyses of Transcription Factor Binding Sites in the Non-Coding Control Region of JC Virus.
Nakamichi Kazuo, et al. Viruses 2021 0 (11) - Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment.
Prezioso Carla, et al. Journal of clinical medicine 2022 0 (2) - Rearrangement in the Hypervariable Region of JC Polyomavirus Genomes Isolated from Patient Samples and Impact on Transcription Factor-Binding Sites and Disease Outcomes.
Wilczek Michael P, et al. International journal of molecular sciences 2022 5 (10) - Two susceptible HLA-DRB1 alleles for multiple sclerosis differentially regulate anti-JC virus antibody serostatus along with fingolimod.
Watanabe Mitsuru, et al. Journal of neuroinflammation 2020 7 (1) 206 - Genetic Study of Severe Prolonged Lymphopenia in Multiple Sclerosis Patients Treated With Dimethyl Fumarate.
Sangurdekar Dipen, et al. Frontiers in genetics 2019 0 1039 - Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia.
Kowalec Kaarina et al. BMJ open 2017 Jun 7(5) e016276 - Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF a: A 18 Month Follow-Up Study.
Rodio Donatella Maria, et al. Frontiers in microbiology 2016 0 672
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: